Singapore has pioneered multiple aspects of QuintilesIMS’s global business, and the high profile merger has created interesting opportunities for the organization within the APAC region, beyond strong synergies at the global level.
It’s a pleasure to meet with you Anand, as this is the first time PharmaBoardroom has met with QuintilesIMS since the merger. With that in mind, would you please introduce the new organization and explain the new strategic direction?
"Our organization in Singapore has led the way globally in developing new business models for entering two new different business areas."
